Common Name |
Sodium stibogluconate
Description |
Sodium stibogluconate is a medicine used to treat leishmaniasis and is only available for administration by injection. It belongs to the class of medicines known as the pentavalent antimonials. Sodium stibogluconate is sold in the UK as Pentostam (manufactured by GlaxoSmithKline). Widespread resistance has limited the utility of sodium stibogluconate, and in many parts of the world, amphotericin or miltefosine are used instead. It is also being investigated as an anti-tumor agent.
Structure |
Synonyms |
Value |
Source |
Antimony (V) derivative OF sodium gluconateChEBI
Antimony sodium gluconateChEBI
estibogluconato SodicoChEBI
MyostibinChEBI
Natrii stibogluconasChEBI
PentostamChEBI
StibanateChEBI
StibanoseChEBI
StibatinChEBI
StibinolChEBI
Stibogluconate de sodiumChEBI
Trisodium 1-{[3-carboxylato-5-(1,2-dihydroxyethyl)-1-hydroxy-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]hept-1-yl]oxy}-5-(1,2-dihydroxyethyl)-1-oxido-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]heptane-3-carboxylate nonahydrateChEBI
Antimony (V) derivative OF sodium gluconic acidGenerator
Sodium stibogluconic acidGenerator
Antimony sodium gluconic acidGenerator
Stibanic acidGenerator
Stibogluconic acid de sodiumGenerator
Trisodium 1-{[3-carboxylato-5-(1,2-dihydroxyethyl)-1-hydroxy-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]hept-1-yl]oxy}-5-(1,2-dihydroxyethyl)-1-oxido-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]heptane-3-carboxylic acid nonahydric acidGenerator
Chemical Formlia |
C12H35Na3O26Sb2
Average Molecliar Weight |
907.88
Monoisotopic Molecliar Weight |
905.918601405
IUPAC Name |
trisodium (3R,4S,5R)-1-{[(3R,4S,5R)-3-carboxylato-5-[(1R)-1,2-dihydroxyethyl]-1-oxido-2,6,7-trioxa-1-stibabicyclo[2.2.1]heptan-1-yl]oxy}-5-[(1R)-1,2-dihydroxyethyl]-1-hydroxy-2,6,7-trioxa-1-stibabicyclo[2.2.1]heptane-3-carboxylate nonahydrate
Traditional Name |
trisodium (3R,4S,5R)-1-{[(3R,4S,5R)-3-carboxylato-5-[(1R)-1,2-dihydroxyethyl]-1-oxido-2,6,7-trioxa-1-stibabicyclo[2.2.1]heptan-1-yl]oxy}-5-[(1R)-1,2-dihydroxyethyl]-1-hydroxy-2,6,7-trioxa-1-stibabicyclo[2.2.1]heptane-3-carboxylate nonahydrate
CAS Registry Number |
16037-91-5
SMILES |
O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[H][C@@]1(O[Sb]2(O)(O[Sb]34([O-])O[C@@H](C([O-])=O)[C@@]([H])(O3)[C@]([H])(O4)[C@H](O)CO)O[C@@H](C([O-])=O)[C@@]1([H])O2)[C@H](O)CO
InChI Identifier |
InChI=1S/2C6H9O7.3Na.10H2O.2O.2Sb/c2*7-1-2(8)3(9)4(10)5(11)6(12)13;;;;;;;;;;;;;;;;;/h2*2-5,7-8H,1H2,(H,12,13);;;;10*1H2;;;;/q2*-3;3*+1;;;;;;;;;;;;-1;+3;+4/p-3/t2*2-,3-,4+,5-;;;;;;;;;;;;;;;;;/m11……………../s1
InChI Key |
YQDGWZZYGYKDLR-UZVLBLASSA-K
Chemical Taxonomy |
Description |
This compound belongs to the class of chemical entities known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups.
Kingdom |
Chemical entities
Super Class |
Organic compounds
Class |
Organic acids and derivatives
Sub Class |
Carboxylic acids and derivatives
Direct Parent |
Dicarboxylic acids and derivatives
Alternative Parents |
Secondary alcohols
Organic antimony salts
Carboxylic acid salts
Oxacyclic compounds
Metalloheterocyclic compounds
Carboxylic acids
Primary alcohols
Organic zwitterions
Organic sodium salts
Organic oxides
Hydrocarbon derivatives
Carbonyl compounds
Substituents |
Dicarboxylic acid or derivatives
Carboxylic acid salt
Secondary alcohol
Organic antimony salt
Organic alkali metal salt
Oxacycle
Organic metal salt
Organic metalloid salt
Carboxylic acid
Organoheterocyclic compound
Metalloheterocycle
Organic oxide
Organic zwitterion
Primary alcohol
Organooxygen compound
Organic salt
Organic oxygen compound
Organic sodium salt
Alcohol
Carbonyl group
Hydrocarbon derivative
Aliphatic heteropolycyclic compound
Molecliar Framework |
Aliphatic heteropolycyclic compounds
External Descriptors |
D-gluconate adduct (CHEBI:28148 )
Ontology |
Status |
Expected but not Quantified
Origin |
Drug
Biofunction |
Anticancer Agents
Antiparasitic Agents
Application |
Pharmaceutical
Cellliar locations |
Cytoplasm
Physical Properties |
State |
Solid
Experimental Properties |
Property |
Value |
Reference |
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties |
Property |
Value |
Source |
logP-3.4ChemAxon
pKa (Strongest Acidic)2.29ChemAxon
pKa (Strongest Basic)-3ChemAxon
Physiological Charge-2ChemAxon
Hydrogen Acceptor Count17ChemAxon
Hydrogen Donor Count5ChemAxon
Polar Surface Area269.08 Å2ChemAxon
Rotatable Bond Count8ChemAxon
Refractivity96.29 m3·mol-1ChemAxon
Polarizability39.78 Å3ChemAxon
Number of Rings4ChemAxon
Bioavailability0ChemAxon
Rlie of FiveYesChemAxon
Ghose FilterYesChemAxon
Vebers RlieYesChemAxon
MDDR-like RlieYesChemAxon
Spectra |
Spectra |
Not Available
Biological Properties |
Cellliar Locations |
Cytoplasm
Biofluid Locations |
Blood
Urine
Tissue Location |
Not Available
Pathways |
Not Available
Normal Concentrations |
Biofluid |
Status |
Age |
Condition |
Reference |
Details |
BloodExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB05630
21059682
details
UrineExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB05630
21059682
details
|
Abnormal Concentrations |
|
Not Available
Associated Disorders and Diseases |
Disease References |
None
Associated OMIM IDs |
None
External Links |
DrugBank ID |
DB05630
DrugBank Metabolite ID |
Not Available
Phenol Explorer Compound ID |
Not Available
Phenol Explorer Metabolite ID |
Not Available
FoodDB ID |
Not Available
KNApSAcK ID |
Not Available
Chemspider ID |
27471272
KEGG Compound ID |
Not Available
BioCyc ID |
Not Available
BiGG ID |
Not Available
Wikipedia Link |
Sodium_stibogluconate
NuGOwiki Link |
HMDB15617
Metagene Link |
HMDB15617
METLIN ID |
Not Available
PubChem Compound |
Not Available
PDB ID |
Not Available
ChEBI ID |
28148
Product: Sulfamerazine
References |
Synthesis Reference |
Not Available |
Material Safety Data Sheet (MSDS) |
Not Available |
General References |
- Murray HW, Berman JD, Davies CR, Saravia NG: Advances in leishmaniasis. Lancet. 2005 Oct 29-Nov 4;366(9496):1561-77. [PubMed:16257344 ]
|
PMID: 17660385